TREVI THERAPEUTICS
Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF), and levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. These conditions share common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Trevi is currently conducting a Phase 2b/3 clinical trial of nalbuphine ER, referred to as the PRISM trial, in patients with severe pruritus associated with prurigo nodularis.
TREVI THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Sandy Hook, Connecticut, United States
Country:
United States
Website Url:
http://www.trevitherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
203-304-2499
Email Addresses:
[email protected]
Total Funding:
156.53 M USD
Technology used in webpage:
Font Awesome HSTS IPv6 ReCAPTCHA Cloudflare Hosting Cloudflare JS CDN JS Facebook Sharer Cloudflare CDN ReCAPTCHA V2
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fairmount Funds Management
Fairmount Funds Management investment in Post-IPO Equity - Trevi Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Trevi Therapeutics
Frazier Life Sciences
Frazier Life Sciences investment in Post-IPO Equity - Trevi Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Trevi Therapeutics
Omega Funds
Omega Funds investment in Series C - Trevi Therapeutics
TPG Biotech
TPG Biotech investment in Series C - Trevi Therapeutics
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Trevi Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series C - Trevi Therapeutics
TPG Biotech
TPG Biotech investment in Series C - Trevi Therapeutics
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Trevi Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-14 | Trevi Therapeutics Appoints Pharma Industry Veteran as Chief Medical Officer |
Official Site Inspections
http://www.trevitherapeutics.com Semrush global rank: 2.79 M Semrush visits lastest month: 6.14 K
- Host name: cloudproxy10117.sucuri.net
- IP address: 192.124.249.117
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Trevi Therapeutics"
Leadership - Trevi Therapeutics
Mr. Heffernan previously founded and served as President and Chief Executive Officer of Clinical Studies Ltd., a pharmaceutical contract research organization that was sold to PhyMatrix …See details»
Trevi Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 203-304-2499 Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious …See details»
Board of Directors|Trevi Therapeutics
Mr. Heffernan previously founded and served as President and Chief Executive Officer of Clinical Studies Ltd., a pharmaceutical contract research organization that was sold to PhyMatrix …See details»
Trevi Therapeutics, Inc. | LinkedIn
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvioâ„¢ (nalbuphine ER).See details»
Trevi Therapeutics Provides Business Update Ahead of Upcoming ...
Jan 5, 2023 Investor Contact Katie McManus Trevi Therapeutics, Inc. 203-304-2499 [email protected]. Media Contact Rosalia Scampoli 914-815-1465 …See details»
Investor Site - Overview - Trevi Therapeutics
Nov 6, 2024 Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvioâ„¢ (oral nalbuphine ER) for the …See details»
Trevi Therapeutics, Inc. (TRVI) Company Profile & Overview - Stock …
May 7, 2019 Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough …See details»
Trevi Therapeutics, Inc. (TRVI) - Yahoo Finance
See the company profile for Trevi Therapeutics, Inc. (TRVI) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Trevi Therapeutics - PitchBook
Trevi Therapeutics General Information Description. Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) …See details»
Company Trevi Therapeutics, Inc. - MarketScreener.com
Feb 28, 2011 Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of the investigational therapy …See details»
Trevi Therapeutics - Products, Competitors, Financials, Employees ...
Jul 5, 2019 trevitherapeutics.com. Overview & Products; Financials; Founded Year 2011. Stage IPO | IPO. Total Raised $102.91M. Date of IPO 5/7/2019. Market Cap 0.21B. Stock Price 2.91. …See details»
Trevi Therapeutics - Overview, News & Similar companies
May 9, 2024 Trevi Therapeutics contact info: Phone number: (203) 304-2499 Website: www.trevitherapeutics.com What does Trevi Therapeutics do? clinical-stage …See details»
Passionate about Progress - Trevi Therapeutics
We are a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvioâ„¢ (oral nalbuphine ER) for patients with difficult to treat chronic cough conditions by …See details»
Trevi Therapeutics Announces Positive Topline Results from …
Dec 3, 2024 Trevi Therapeutics, Inc. www.trevitherapeutics.com (PRNewsfoto/Trevi Therapeutics, Inc.) The HAP study was a randomized, double-blind, double-dummy, active …See details»
Trevi Therapeutics - Craft
Trevi Therapeutics has 5 employees at their 1 location and $14.07 m in annual revenue in FY 2018. See insights on Trevi Therapeutics including office locations, competitors, revenue, …See details»
Trevi Therapeutics, Inc. (TRVI) - Yahoo Finance
Find the latest Trevi Therapeutics, Inc. (TRVI) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Trevi Therapeutics Announces Abstract Presentation at the …
Apr 9, 2024 Trevi Therapeutics, Inc. www.trevitherapeutics.com (PRNewsfoto/Trevi Therapeutics, Inc.) ATS 2024 International Conference May 17-22, 2024, San Diego, CA …See details»
Trevi Therapeutics, Inc. (TRVI) Stock Price, News, Quote & History ...
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic …See details»
Haduvioâ„¢ - Trevi Therapeutics
The cause of chronic cough is thought to be the result of a hypersensitivity disorder where a stimulus, either chemical or mechanical, sends a message to the brain, through the brainstem, …See details»